Predictive Value of RDW/PLT for Progression of COVID-19 Pneumonia: A Potential Biomarker for Disease Severity
DOI:
https://doi.org/10.54536/ajlsi.v3i1.2441Keywords:
COVID-19, Pneumonia, Disease Progression, Biomarker, Clinical Decision-MakingAbstract
Identifying reliable predictors for COVID-19 pneumonia progression is crucial for effective patient management. The purpose of this study is to evaluate the Red Cell Distribution Width to Platelet Ratio (RDW/PLT) as a potential predictive biomarker for the development of moderate to severe COVID-19 pneumonia. Conducting a retrospective analysis from August 2021 to March 2023, we categorized patients with moderate COVID-19 pneumonia at admission into different severity groups. The objective was to explore clinical and laboratory variables associated with disease progression. Fifty-three patients initially diagnosed with moderate COVID-19 were studied, of which 17 progressed to severe disease. Univariate logistic regression analyzed various factors, including age, PLT, RDW-SD, RDW/PLT, AST, ALB, CRP, and IL-6, evaluating their correlation (P < 0.05) with higher odds ratios of a poor prognosis. To ascertain these factors’ predictive power, Receiver Operating Characteristic (ROC) curve analysis was used. Univariate logistic regression highlighted several factors associated with increased odds ratios for poor prognosis. Notably, RDW/PLT exhibited the highest predictive value (AUC: 0.925, 95% CI 0.858–0.991) among single parameters in predicting the risk of COVID-19 progression. This study underscores the potential of RDW/PLT as an accessible and cost-effective biomarker for determining COVID-19 pneumonia severity. The findings support its utility in risk stratification and clinical decision-making, offering valuable insights for effective patient management strategies.
Downloads
References
Albahri, O. S., Al-Obaidi, J. R., Zaidan, A., Albahri, A. S., Zaidan, B., Salih, M. M., Qays, A., Dawood, K. A., Mohammed, R., & Abdulkareem, K. H. (2020). Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods. Computer methods and programs in biomedicine, 196, 105617.
Alballa, N., & Al-Turaiki, I. (2021). Machine learning approaches in COVID-19 diagnosis, mortality, and severity risk prediction: A review. Informatics in medicine unlocked, 24, 100564.
Alnor, A., Sandberg, M. B., Gils, C., & Vinholt, P. J. (2020). Laboratory tests and outcome for patients with coronavirus disease 2019: a systematic review and meta-analysis. The journal of applied laboratory medicine, 5(5), 1038-1049.
Althaus, K., Marini, I., Zlamal, J., Pelzl, L., Singh, A., Häberle, H., Mehrländer, M., Hammer, S., Schulze, H., & Bitzer, M. (2021). Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood, The Journal of the American Society of Hematology, 137(8), 1061-1071.
Ballaz, S. J., Pulgar-Sánchez, M., Chamorro, K., Fernández-Moreira, E., Ramírez, H., Mora, F. X., & Fors, M. (2021). Common laboratory tests as indicators of COVID-19 severity on admission at high altitude: a single-center retrospective study in Quito (ECUADOR). Clinical Chemistry and Laboratory Medicine (CCLM), 59(8), e326-e329.
Bonetti, G., Manelli, F., Patroni, A., Bettinardi, A., Borrelli, G., Fiordalisi, G., Marino, A., Menolfi, A., Saggini, S., & Volpi, R. (2020). Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy. Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), 1100-1105.
Borghesi, A., Zigliani, A., Masciullo, R., Golemi, S., Maculotti, P., Farina, D., & Maroldi, R. (2020). Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients. La radiologia medica, 125, 461-464.
Cai, Y., Liu, D., Cui, J., Sha, Y., Zhou, H., Tang, N., Wang, N., Huang, A., & Xia, J. (2019). Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: A systematic review and meta-analysis. Medicine, 98(14).
Cases, C. (2020). Worldometer. Retrieved on, 30.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., & Wei, Y. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet, 395(10223), 507-513.
Fernandes, F. T., de Oliveira, T. A., Teixeira, C. E., Batista, A. F. d. M., Dalla Costa, G., & Chiavegatto Filho, A. D. P. (2021). A multipurpose machine learning approach to predict COVID-19 negative prognosis in São Paulo, Brazil. Scientific reports, 11(1), 3343.
Foy, B. H., Carlson, J. C., Reinertsen, E., Valls, R. P., Lopez, R. P., Palanques-Tost, E., ... & Higgins, J. M. (2020). Elevated RDW is associated with increased mortality risk in COVID-19. medRxiv, 2020-05.
Foy, B. H., Carlson, J. C., Reinertsen, E., Valls, R. P. I., Lopez, R. P., Palanques-Tost, E., Mow, C., Westover, M. B., Aguirre, A. D., & Higgins, J. M. (2020b). Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA network open, 3(9), e2022058-e2022058.
Ghahramani, S., Tabrizi, R., Lankarani, K. B., Kashani, S. M. A., Rezaei, S., Zeidi, N., Akbari, M., Heydari, S. T., Akbari, H., Nowrouzi-Sohrabi, P., & Ahmadizar, F. (2020). Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res, 25(1), 30. https://doi.org/10.1186/s40001-020-00432-3
Gong, K., Wu, D., Arru, C. D., Homayounieh, F., Neumark, N., Guan, J., Buch, V., Kim, K., Bizzo, B. C., & Ren, H. (2021). A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records. European journal of radiology, 139, 109583.
Henry, B. M., Aggarwal, G., Wong, J., Benoit, S., Vikse, J., Plebani, M., & Lippi, G. (2020). Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. The American journal of emergency medicine, 38(9), 1722-1726.
Henry, B. M., De Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020). Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), 1021-1028.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., & Gu, X. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
Khosravi, B., Aghaghazvini, L., Sorouri, M., Atashi, S. N., Abdollahi, M., Mojtabavi, H., Khodabakhshi, M., Motamedi, F., Azizi, F., & Rajabi, Z. (2021). Predictive value of initial CT scan for various adverse outcomes in patients with COVID-19 pneumonia. Heart & Lung, 50(1), 13-20.
Kilercik, M., Demirelce, Ö., Serdar, M. A., Mikailova, P., & Serteser, M. (2021). A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients. PLoS One, 16(8), e0254073.
Krintus, M., Kozinski, M., Kubica, J., & Sypniewska, G. (2014). Critical appraisal of inflammatory markers in cardiovascular risk stratification. Critical reviews in clinical laboratory sciences, 51(5), 263-279.
Levi, M., Thachil, J., Iba, T., & Levy, J. H. (2020). Coagulation abnormalities and thrombosis in patients with COVID-19. The Lancet Haematology, 7(6), e438-e440.
Li, X., Liu, C., Mao, Z., Xiao, M., Wang, L., Qi, S., & Zhou, F. (2020). Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Critical Care, 24(1), 1-10.
Lippi, G., & Favaloro, E. J. (2020). D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thrombosis and haemostasis, 120(05), 876-878.
Lippi, G., & Mattiuzzi, C. (2020). Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematology, transfusion and cell therapy, 42, 116-117.
Lippi, G., & Plebani, M. (2020). The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), 1063-1069.
Liu, X., Zhang, R., & He, G. (2020). Hematological findings in coronavirus disease 2019: indications of progression of disease. Annals of hematology, 99, 1421-1428.
Patel, H. H., Patel, H. R., & Higgins, J. M. (2015). Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease. American journal of hematology, 90(5), 422-428.
Pongpirul, W. A., Wiboonchutikul, S., Charoenpong, L., Panitantum, N., Vachiraphan, A., Uttayamakul, S., Pongpirul, K., Manosuthi, W., & Prasithsirikul, W. (2020). Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): A retrospective observational analysis of 193 confirmed cases in Thailand. PLoS neglected tropical diseases, 14(10), e0008806.
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020). Biomarkers associated with COVID-19 disease progression. Critical reviews in clinical laboratory sciences, 57(6), 389-399.
Pulgar-Sánchez, M., Chamorro, K., Fors, M., Mora, F. X., Ramírez, H., Fernandez-Moreira, E., & Ballaz, S. J. (2021). Biomarkers of severe COVID-19 pneumonia on admission using data-mining powered by common laboratory blood tests-datasets. Comput Biol Med, 136, 104738. https://doi.org/10.1016/j.compbiomed.2021.104738
Sharma, A., Rani, S., & Gupta, D. (2020). Artificial intelligence-based classification of chest X-ray images into COVID-19 and other infectious diseases. International journal of biomedical imaging, 2020, 1-10.
Shiri, I., Sorouri, M., Geramifar, P., Nazari, M., Abdollahi, M., Salimi, Y., Khosravi, B., Askari, D., Aghaghazvini, L., & Hajianfar, G. (2021). Machine learning-based prognostic modeling using clinical data and quantitative radiomic features from chest CT images in COVID-19 patients. Computers in biology and medicine, 132, 104304.
Sun, S., Cai, X., Wang, H., He, G., Lin, Y., Lu, B., Chen, C., Pan, Y., & Hu, X. (2020). Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clinica chimica acta, 507, 174-180.
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology, 20(6), 363-374.
Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., Chen, H., Wang, D., Liu, N., & Liu, D. (2020). Characteristics of COVID-19 infection in Beijing. Journal of infection, 80(4), 401-406.
Tjendra, Y., Al Mana, A. F., Espejo, A. P., Akgun, Y., Millan, N. C., Gomez-Fernandez, C., & Cray, C. (2020). Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers. Archives of pathology & laboratory medicine, 144(12), 1465-1474.
Ullah, W., Basyal, B., Tariq, S., Almas, T., Saeed, R., Roomi, S., Haq, S., Madara, J., Boigon, M., & Haas, D. C. (2020). Lymphocyte-to-C-reactive protein ratio: a novel predictor of adverse outcomes in COVID-19. Journal of clinical medicine research, 12(7), 415.
Wang, C., Deng, R., Gou, L., Fu, Z., Zhang, X., Shao, F., Wang, G., Fu, W., Xiao, J., & Ding, X. (2020). Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Annals of translational medicine, 8(9).
Wang, X., Li, X., Shang, Y., Wang, J., Zhang, X., Su, D., Zhao, S., Wang, Q., Liu, L., & Li, Y. (2020). Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre. Epidemiology & Infection, 148, e211.
Wang, Y., Li, X., Xu, J., & Zhou, Q. (2022). A complete blood count-based multivariate model for predicting the recovery of patients with moderate COVID-19: a retrospective study. Scientific reports, 12(1), 18262.
Wynants, L., Van Calster, B., Collins, G. S., Riley, R. D., Heinze, G., Schuit, E., Albu, E., Arshi, B., Bellou, V., & Bonten, M. M. (2020). Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. bmj, 369.
Xu, P., Zhou, Q., & Xu, J. (2020). Mechanism of thrombocytopenia in COVID-19 patients. Annals of hematology, 99(6), 1205-1208.
Yamada, T., Wakabayashi, M., Yamaji, T., Chopra, N., Mikami, T., Miyashita, H., & Miyashita, S. (2020). Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Clinica chimica acta, 509, 235-243.
Yuan, X., Huang, W., Ye, B., Chen, C., Huang, R., Wu, F., Wei, Q., Zhang, W., & Hu, J. (2020). Changes of hematological and immunological parameters in COVID-19 patients. International journal of hematology, 112, 553-559.
Zhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020). Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. International journal of antimicrobial agents, 55(5), 105954.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., & Gu, X. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 395(10229), 1054-1062.
Zorlu, A., Bektasoglu, G., Guven, F. M. K., Dogan, O. T., Gucuk, E., Ege, M. R., Altay, H., Cınar, Z., Tandogan, I., & Yilmaz, M. B. (2012). Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. The American journal of cardiology, 109(1), 128-134.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Suming Zhang, Kang Huang, Salwa M. Imran, Wafa Mohammad, Pengfei Liu, Yali Chao
This work is licensed under a Creative Commons Attribution 4.0 International License.
